» Articles » PMID: 30332826

Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2018 Oct 19
PMID 30332826
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Low-dose radiotherapy (LD-RT) for benign inflammatory and/or bone destructive diseases has been used long. Therefore, mechanistic investigations on cells being present in joints are mostly made in an inflammatory setting. This raises the question whether similar effects of LD-RT are also seen in healthy tissue and thus might cause possible harmful effects. We performed examinations on the functionality and phenotype of key cells within the joint, namely on fibroblast-like synoviocytes (FLS), osteoclasts and osteoblasts, as well as on immune cells. Low doses of ionizing radiation showed only a minor impact on cytokine release by healthy FLS as well as on molecules involved in cartilage and bone destruction and had no significant impact on cell death and migration properties. The bone resorbing abilities of healthy osteoclasts was slightly reduced following LD-RT and a positive impact on bone formation of healthy osteoblasts was observed after in particular exposure to 0.5 Gray (Gy). Cell death rates of bone-marrow cells were only marginally increased and immune cell composition of the bone marrow showed a slight shift from CD8⁺ to CD4⁺ T cell subsets. Taken together, our results indicate that LD-RT with particularly a single dose of 0.5 Gy has no harmful effects on cells of healthy joints.

Citing Articles

Osteo-immunological impact of radon spa treatment: due to radon or spa alone? Results from the prospective, thermal bath placebo-controlled RAD-ON02 trial.

Eckert D, Evic M, Schang J, Isbruch M, Er M, Dorrschuck L Front Immunol. 2024; 14:1284609.

PMID: 38292488 PMC: 10824901. DOI: 10.3389/fimmu.2023.1284609.


Preventive and therapeutic effects of low-dose whole-body irradiation on collagen-induced rheumatoid arthritis in mice.

Kim J, Lee Y, Lee Y, Song C, Han S, Cho S J Radiat Res. 2023; 65(2):177-186.

PMID: 38155365 PMC: 10959428. DOI: 10.1093/jrr/rrad101.


Neglected immunoregulation: M2 polarization of macrophages triggered by low-dose irradiation plays an important role in bone regeneration.

Chen S, Ni S, Liu C, He M, Pan Y, Cui P J Cell Mol Med. 2023; 27(8):1095-1109.

PMID: 36929666 PMC: 10098298. DOI: 10.1111/jcmm.17721.


Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.

Weissmann T, Ruckert M, Putz F, Donaubauer A, Hecht M, Schnellhardt S Strahlenther Onkol. 2023; 199(12):1164-1172.

PMID: 36602569 PMC: 10674008. DOI: 10.1007/s00066-022-02038-6.


Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray Exposure.

Eckert D, Rapp F, Tsedeke A, Kraft D, Wente I, Molendowska J Front Immunol. 2022; 13:817281.

PMID: 35603191 PMC: 9116137. DOI: 10.3389/fimmu.2022.817281.


References
1.
Derer A, Deloch L, Rubner Y, Fietkau R, Frey B, Gaipl U . Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol. 2015; 6:505. PMC: 4597129. DOI: 10.3389/fimmu.2015.00505. View

2.
Frey B, Ruckert M, Deloch L, Ruhle P, Derer A, Fietkau R . Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. Immunol Rev. 2017; 280(1):231-248. DOI: 10.1111/imr.12572. View

3.
Redlich K, Hayer S, Ricci R, David J, Tohidast-Akrad M, Kollias G . Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest. 2002; 110(10):1419-27. PMC: 151809. DOI: 10.1172/JCI15582. View

4.
Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y . Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000; 141(9):3478-84. DOI: 10.1210/endo.141.9.7634. View

5.
Ott O, Jeremias C, Gaipl U, Frey B, Schmidt M, Fietkau R . Radiotherapy for benign achillodynia. Long-term results of the Erlangen Dose Optimization Trial. Strahlenther Onkol. 2015; 191(12):979-84. DOI: 10.1007/s00066-015-0893-4. View